New drug shows promise for cortisol disorder in phase 3 trial
NCT ID NCT04308590
First seen Nov 01, 2025 · Last updated May 16, 2026 · Updated 30 times
Summary
This study tested a drug called relacorilant in 137 people with high cortisol levels due to non-cancerous adrenal gland growths. The goal was to see if the drug could improve blood pressure and blood sugar control. Participants received either the drug or a placebo, and researchers measured changes over time.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPERCORTISOLISM are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Site 01
Wilmington, North Carolina, 28401, United States
-
Site 02
Summerville, South Carolina, 29485, United States
-
Site 03
El Paso, Texas, 79935, United States
-
Site 05
Fort Worth, Texas, 76132, United States
-
Site 06
Jackson, Mississippi, 39202, United States
-
Site 07
Atlanta, Georgia, 30318, United States
-
Site 08
Houston, Texas, 77079, United States
-
Site 09
Metairie, Louisiana, 70006, United States
-
Site 10
Jamaica, New York, 11432, United States
-
Site 11
Fall River, Massachusetts, 02721, United States
-
Site 13
Seville, 41013, Spain
-
Site 14
Málaga, 29006, Spain
-
Site 15
Spokane, Washington, 99202, United States
-
Site 16
Indianapolis, Indiana, 46202, United States
-
Site 17
Stanford, California, 94305, United States
-
Site 20
Dallas, Texas, 75390, United States
-
Site 21
Columbus, Ohio, 43201-3209, United States
-
Site 22
Sofia, 01431, Bulgaria
-
Site 23
Tel Aviv, Israel
-
Site 25
Vienna, State of Vienna, 1090, Austria
-
Site 26
Valencia, 46026, Spain
-
Site 27
Birmingham, Alabama, 35294, United States
-
Site 28
Naples, 80131, Italy
-
Site 30
Cleveland, Ohio, 44195, United States
-
Site 31
Rome, Roma, 00189, Italy
-
Site 32
Ramat Gan, 5265601, Israel
-
Site 33
Rochester, Minnesota, 55905, United States
-
Site 34
Milan, Italy
-
Site 35
Lublin, Poland
-
Site 36
Baltimore, Maryland, 21287, United States
-
Site 37
Rome, 00161, Italy
-
Site 38
Bucharest, 011863, Romania
-
Site 40
Milan, Milano, 20122, Italy
-
Site 41
Bucharest, 011863, Romania
-
Site 42
Bucharest, 010825, Romania
-
Site 43
Orbassano, Torino, Italy
-
Site 44
New York, New York, 10021, United States
-
Site 46
Würzburg, 97080, Germany
-
Site 47
Krakow, 31-501, Poland
-
Site 48
Gliwice, 44-102, Poland
-
Site 50
Munich, Bavaria, 80336, Germany
-
Site 51
Padova, 35128, Italy
-
Site 52
Torino, 10126, Italy
-
Site 53
Torrance, California, 90502, United States
-
Site 54
Reno, Nevada, 89511, United States
Conditions
Explore the condition pages connected to this study.